Exagen Inc.
XGN
$6.50
-$0.38-5.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.18% | -16.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.18% | -16.97% | |||
| Cost of Revenue | -6.30% | -8.02% | |||
| Gross Profit | 21.43% | -22.91% | |||
| SG&A Expenses | 0.40% | -2.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.77% | -2.73% | |||
| Operating Income | 27.45% | -80.25% | |||
| Income Before Tax | 25.44% | -69.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.20% | -69.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.20% | -69.52% | |||
| EBIT | 27.45% | -80.25% | |||
| EBITDA | 30.02% | -96.52% | |||
| EPS Basic | 25.89% | -68.75% | |||
| Normalized Basic EPS | 26.09% | -68.73% | |||
| EPS Diluted | 25.89% | -68.75% | |||
| Normalized Diluted EPS | 26.09% | -68.73% | |||
| Average Basic Shares Outstanding | 0.95% | 0.42% | |||
| Average Diluted Shares Outstanding | 0.95% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||